ASCO-GI 2021: Addition of Docetaxel to S-1 Chemotherapy Improves Outcomes in Stage III Gastric Cancer
Given after surgery, the combination was also safe and well-tolerated
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.